Crovalimab | Interleukin Related interleukin-related.com

Product Name :
Crovalimab

Search keywords :
Crovalimab

drugId :
null

Target Vo:
Complement C5

Target Vo Short Name :
C5

Moa_Name:
Complement C5 inhibitors

First Approval Country :
Mainland China

First Approval Date Filter:
2024

Origin Company_Name :
Chugai Pharmaceutical Co Ltd

Active Company_Name :
Chugai Pharmaceutical Co Ltd

Active Indication_Name:
Hemoglobinuria, Paroxysmal

In Active Indication_Name:
Guillain-Barre Syndrome

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Loncastuximab tesirine Biological Activity
Integrin alpha 5 Rabbit mAb supplier
Beta Actin Antibody HRP Conjugated: Beta Actin Antibody HRP Conjugated is a rabbit-derived HRP-conjugated antibody targeting beta-Actin with a molecular weight of approximately 42 KDa. Beta Actin Antibody HRP Conjugated can be used for WB experiments in human, mouse, rat, zebrafish, monkey, hamster, plant backgrounds.

Author: Interleukin Related

Related Posts